Cited by 466Neuroinflammation and Neurodegeneration MechanismsPluripotent Stem Cells ResearchNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Development and validation of a simplified method to generate human microglia from pluripotent stem cells

Open access

McQuade, Amanda, Coburn, Morgan, Tu, Christina H., Hasselmann, Jonathan, Davtyan, Hayk, Blurton-Jones, Mathew·2018·Molecular Neurodegeneration

DOI 10.1186/s13024-018-0297-xPMC PMC6303871

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Microglia, the principle immune cells of the brain, play important roles in neuronal development, homeostatic function and neurodegenerative disease. Recent genetic studies have further highlighted the importance of microglia in neurodegeneration with the identification of disease risk polymorphisms in many microglial genes. To better understand the role of these genes in microglial biology and disease, we, and others, have developed methods to differentiate microglia from human induced pluripotent stem cells (iPSCs). While the development of these methods has begun to enable important new studies of microglial biology, labs with little prior stem cell experience have sometimes found it challenging to adopt these complex protocols. Therefore, we have now developed a greatly simplified approach to generate large numbers of highly pure human microglia. RESULTS: hematopoietic progenitors are then simply transferred to media that includes three key cytokines (M-CSF, IL-34, and TGFβ-1) that promote differentiation of homeostatic microglia. This updated approach avoids the prior requirement for hypoxic incubation, complex media formulation, FACS sorting, or co-culture, thereby significantly simplifying human microglial generation. To confirm that the resulting cells are equivalent to previously developed iPSC-microglia, we performed RNA-sequencing, functional testing, and transplantation studies. Our findings reveal that microglia generated via this simplified method are virtually identical to iPS-microglia produced via our previously published approach. To also determine whether a small molecule activator of TGFβ signaling (IDE1) can be used to replace recombinant TGFβ1, further reducing costs, we examined growth kinetics and the transcriptome of cells differentiated with IDE1. These data demonstrate that a microglial cell can indeed be produced using this alternative approach, although transcriptional differences do occur that should be considered. CONCLUSION: We anticipate that this new and greatly simplified protocol will enable many interested labs, including those with little prior stem cell or flow cytometry experience, to generate and study human iPS-microglia. By combining this method with other advances such as CRISPR-gene editing and xenotransplantation, the field will continue to improve our understanding of microglial biology and their important roles in human development, homeostasis, and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13024-018-0297-x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 A simplified microglial differentiation protocol can be used to produce large numbers of highly pure human microglia. Schematic showing the process of differentiation from iPSCs through the mesoderm lineage (days 0–3) and further promoting hematopoiesis (days 3–11). Primitive hematopoietic progenitor cells begin to appear on day 7 (black arrows) and by day 11 large numbers of round non-adherent HPCs are observed. Floating HPCs are then transferred into new medium to induce microglial differentiation for 27 days. The last 3 days of microglial differentiation include additional neuronal and astrocytic ligands to further educate microglia toward a brain-like, homeostatic environment. By day 38, large numbers of highly pure microglia that stain positively for both P2RY12 and TREM2 (> 94%) have been produced and are ready for experimentationCC BY · PubMed Central

Fig. 2 iPS-microglia 2.0 are virtually identical to iPS-microglia generated using a more complex protocol. a Principle component analysis demonstrates that iPS-microglia 2.0 (dark blue) and iPS-microglia differentiated using our previously published protocol (blue) exhibit highly equivalent gene expression profiles that cluster closely with cultured human fetal and adult microglia (light blue and teal). Additionally, these cells are distinct from human CD14+ monocytes (purple) and CD16+ inflammatory monocytes (pink), and dendritic cells (maroon). b Principal component analysis using a gene list enriched for 882 microglial genes from (Gosselin et al., 2017), further demonstrates the equivalent gene expression between iPS-microglia and fetal and adult microglia. This analysis also highlights the trajectory of differentiation from iPSCs to Microglia and shows the separation between our protocol and monocytic and dendritic cell populations. c Volcano plot of differential expression analysis (p < 0.001, log2(FC) > 2) between iPS-HPC and iPS-HPC 2.0 samples (top) as well as iPS-microglia and iPS-microglia 2.0 (bottom). Significantly increased or decreased genes are shown in coral or blue respectively. d Heatmap using 882 microglial-enriched genes further demonstrates the highly similar gene expression profiles between iPS-microglia and iPS-microglia 2.0 and the close similarity of both cell populations to fetal and adult cultured microgliaCC BY · PubMed Central

Fig. 3 iPS-microglia 2.0 are distinct from CD14+ and CD16+ monocytes Microglia differentiated using our published protocol are distinct from CD14+ monocytes and CD16+ inflammatory monocytes. In order to ensure our iPS-microglia 2.0 are similarly distinct from monocytes, differential expression analysis was computed with DEseq2. a Volcano plots of differentially expressed genes comparing genes enriched in CD16+ monocytes (pink) with genes enriched in iPSmicroglia 2.0 (dark blue) or iPS-microglia (light blue) show many significant differences between monocytes and microglia. Venn diagrams and comparative fold change plots of differentially expressed genes show that the vast majority of differences are identical between iPS-microglia and iPS-microglia 2.0 when compared to CD16+ monocytes. Direct comparisons of the fold change expression level (TPM) of every gene are shown in comparative fold change plots which demonstrate the striking similarity of differential expression when iPS-microglia and iPS-microglia 2.0 are each compared to CD16+ monocytes. b The same is true for comparisons of iPS-microglia and iPS-microglia 2.0 with CD14+ monocytes (purple)CC BY · PubMed Central

Fig. 4 iPS-microglia 2.0 exhibit equivalent substrate-dependent phagocytosis. iPS-microglia and iPS-microglia 2.0 were exposed to fluorescent beta-amyloid fibrils, pHrodo tagged S. aureus, or pHrodo tagged Zymosan A bioparticles from S. cerevisiae. Quantification of the percent of total cells with positive fluorescent signal and the mean fluorescence intensity of that signal is shown on the left. No significance differences were found between each differentiation type, demonstrating the equivalent functional activity of microglia generated by these two differentiation paradigms. Representative images of phase, CD45 staining, and the fluorescent signal of beta-amyloid (top), S. aureus (middle), and Zymosan A (bottom) are shown on the right. One representative image of 10,000 quantified images is shown for iPS-microglia 2.0 (top of each set) and iPS-microglia (bottom of each set)CC BY · PubMed Central

Fig. 5 Transplanted iPS-microglia 2.0 display typical microglial markers and morphology comparable to our previously described iPS-microglia. Adult 2 month old MITRG mice were transplanted with (a-d & i-j, top rows) iPS-microglia 2.0 or (e-h & m-p, bottom rows) iPS-microglia. Brains were harvested 2 months post-transplant. Representative images of cortical (a-h) and hippocampal (i-p) transplanted cells demonstrate complex process ramification and typical tiling. Transplanted iPS-microglia and iPS-microglia 2.0 both express Iba-1 (Overlay images c, g, k, & o, red) and the microglia specific marker, P2RY12 (Overlay images d, h, l, & p, red) and demonstrate human nuclear staining (Ku80, green). Additionally, transplanted human microglia can be seen integrating and tiling with the endogenous mouse microglia population (Arrows indicate Iba1+/Ku80- cells)CC BY · PubMed Central

Fig. 6 The small molecule compound IDE1 can be used in place of TGFβ-1 to produce iPS-microglia. IDE1 and IDE2 were added to microglia cultures in place of TGFβ-1 at the indicated concentrations. a Growth curves from the first 3.5 days of microglial differentiation show that IDE2 is insufficient to allow proliferation of these cells. In contrast, IDE1 (blue) at lower concentrations shows similar growth kinetics to TGFβ control cells (green). b Correlation matrix displaying all samples analyzed in this manuscript shows cells differentiated with IDE1 cluster closely with iPS-microglia 2.0 and are actually more similar to fetal and adult microglia than TGFβ control microglia. c Gene ontology analysis using the Reactome database displays differences between IDE1 treated cells and TGFβ (FDR < 0.001, FC > 2). Enrichment in IDE samples reflects an increased expression of genes within this GO family in IDE1 treated cellsCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Near-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154
Self-citation
Differential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models
Friedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662

Show all 33 references

Sorted by citations

Items 201–300 of 466

Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage
Branscome, H., Khatkar, P., Sharif, S. A., Yin, D., Jacob, S., Cowen, M., Kim, Y., Erickson, J. W., Brantner, C. A., El‐Hage, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05848-x · Cited by 15
A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders
Rubio, A. D., Hamilton, L. L., Bausch, M., Jin, M., Papetti, A. V., Jiang, P., & Yelamanchili, S. V. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10181-x · Cited by 17
Parkinson’s disease risk enhancers in microglia
Booms, A., Pierce, S. E., der Schans, E. J. C. V., & Coetzee, G. A. (2024) · iScience · doi:10.1016/j.isci.2024.108921 · Cited by 14
Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration
Ramaswami, G., Yuva-Aydemir, Y., Akerberg, B. N., Matthews, B. J., Williams, J., Golczer, G., Huang, J., Abdullatif, A. A., Huh, D., Burkly, L. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52311-0 · Cited by 18
Detection and Functional Evaluation of the P2X7 Receptor in hiPSC Derived Neurons and Microglia-Like Cells
Francistiová, L., Vörös, K., Lovász, Z., Dinnyés, A., & Kobolák, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.793769 · Cited by 14
Modeling brain macrophage biology and neurodegenerative diseases using human iPSC-derived neuroimmune organoids
Cerneckis, J., & Shi, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1198715 · Cited by 14
Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models
Rõlova, T., Lehtonen, Š., Goldsteins, G., Kettunen, P., & Koıstınaho, J. (2020) · Stem Cells · doi:10.1002/stem.3309 · Cited by 14
Shaping the Microglia in Retinal Degenerative Diseases Using Stem Cell Therapy: Practice and Prospects
Jin, N., Sha, W., & Gao, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741368 · Cited by 16
Pathogenic mutations in Leucine-rich repeat kinase 2 sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microgliaPreprint
Mamais, A., Landeck, N., Langston, R., Bonet-Ponce, L., Smith, N., Beilina, A., Kaganovich, A., Ghosh, M., Pellegrini, L., Kluss, J. H., et al. (2020) · bioRxiv · doi:10.1101/2020.07.27.219501 · Cited by 4
Stem Cell Models for Context-Specific Modeling in Psychiatric Disorders
Seah, C., Huckins, L. M., & Brennand, K. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.033 · Cited by 12
Differential effects of SORL1 deficiency on the endo-lysosomal network in human neurons and microglia
Mishra, S., Jayadev, S., & Young, J. E. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0389 · Cited by 13
Uptake of alpha‐synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia
Niskanen, J., Peltonen, S., Ohtonen, S., Fazaludeen, M. F., Luk, K. C., Giudice, L., Koıstınaho, J., Malm, T., Goldsteins, G., Albert, K., et al. (2024) · Glia · doi:10.1002/glia.24626 · Cited by 16
Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy
Brandão, W. N., Jain, N., Yin, Z., Kleemann, K. L., Carpenter, M., Bao, X., Serrano, J. R., Tycksen, E., Durão, A. C. C. D. S., Barry, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3690 · Cited by 13
Self-citation
Decoding microglial functions in Alzheimer’s disease: insights from human models
Rao, C., Semrau, S., & Fossati, V. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.02.011 · Cited by 14
Modelling multiple sclerosis using induced pluripotent stem cells
Martínez-Larrosa, J., Matute‐Blanch, C., Montalbán, X., & Comabella, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577425 · Cited by 14
Novel fully human high-affinity anti-TREM2 antibody shows efficacy in clinically relevant Alzheimer´s mouse model
Kraller, M., Faßbender, J., Jabali, A., Kroeger, J. A., Fink, B., Popper, B., Ungerer, M., & Christlmeier, M. A. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01759-x · Cited by 13
Extracellular tau clearance is governed by its aggregation state and independent of microglial activation by LPS and IFN-γ
Shultz, A., Vincze, A., Yau, T. T., Poirier, E. L., Demanche, H., & Rauch, J. N. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107058 · Cited by 13
Transcriptomic analysis unveils bona fide molecular signatures of microglia under conditions of homeostasis and viral encephalitis
Mulenge, F., Gern, O. L., Busker, L. M., Aringo, A., Ghita, L., Waltl, I., Pavlou, A., & Kalinke, U. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03197-2 · Cited by 12
Alzheimer's Disease Risk Gene SORL1 Promotes Receptiveness of Human Microglia to Pro‐Inflammatory Stimuli
Ovesen, P. L., Juul‐Madsen, K., Telugu, N. S., Schmidt, V., Frahm, S., Radbruch, H., Louth, E. L., Korshøj, A. R., Heppner, F. L., Diecke, S., et al. (2025) · Glia · doi:10.1002/glia.24659 · Cited by 14
Efficient and Easy Conversion of Human iPSCs into Functional Induced Microglia-like Cells
Lanfer, J., Kaindl, J., Krumm, L., Acera, M. G., Neurath, M. F., Regensburger, M., Krach, F., & Winner, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094526 · Cited by 14
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Guo, X., Wang, X., Wang, J., Ma, M., & Ren, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083774 · Cited by 15
Human microglia differentially respond to β‐amyloid, tau, and combined Alzheimer's disease pathologies in vivo
Coburn, M., Eskandari‐Sedighi, G., Hasselmann, J., England, W., Shabestari, S. K., Mansour, K., McQuade, A., Mgerian, M., Chadarevian, J. P., Tu, C. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70930 · Cited by 12
Self-citation
Human pluripotent stem cell (hPSC)-derived microglia for the study of brain disorders. A comprehensive review of existing protocols
Teo, F., Kok, C. Y. L., Tan, M.-J., & Je, H. S. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.03.005 · Cited by 11
HDAC Inhibitors recapitulate Human Disease-Associated Microglia Signatures in vitro
Haage, V. C., Tuddenham, J. F., Bautista, A. R., Garcia, F. G., White, C. C., Patel, R., Comandante-Lou, N., Marshe, V. S., Griffin, J. K., Zhou, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.05.027 · Cited by 23
Comparing the Characteristics of Microglia Preparations Generated Using Different Human iPSC-Based Differentiation Methods to Model Neurodegenerative Diseases
Tang, Y. M., Pulimood, N. S., & Stifani, S. (2022) · ASN NEURO · doi:10.1177/17590914221145105 · Cited by 10
CRISPR generation of CSF1R-G795A human microglia for robust microglia replacement in a chimeric mouse model
Chadarevian, J. P., Davtyan, H., Lombroso, S. I., Bennett, F. C., & Blurton-Jones, M. M. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102490 · Cited by 11
Self-citation
Microglia Influence Neurofilament Deposition in ALS iPSC-Derived Motor Neurons
Allison, R. L., Adelman, J. W., Abrudan, J., Urrutia, R. A., Zimmermann, M. T., Mathison, A., & Ebert, A. D. (2022) · Genes · doi:10.3390/genes13020241 · Cited by 11
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells
Muhtaseb, A. W., & Duan, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.04.003 · Cited by 11
Circulatory proteins shape microglia state and boost phagocytosisPreprint
Lu, N., Losada, P. M., Hahn, O., Saksena, A., Tapp, E., Chadarevian, J. P., Dong, W., Shi, S. M., Shuken, S. R., Guldner, I. H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.30.615861 · Cited by 12
Self-citation
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer’s disease
Weerakkody, T. N., Sabelström, H., Andrews, S. V., Chadarevian, J. P., Chin, M. Y., Tatarakis, D., Propson, N. E., Kim, D. J., Theolis, R., Parico, G. C. G., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw7428 · Cited by 12
Self-citation
SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment
Kamińska, P., Ovesen, P. L., Jakiel, M., Obrębski, T., Schmidt, V., Dramiński, M., Bilska, A. G., Bieniek, M., Anink, J. J., Paterczyk, B., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00117-6 · Cited by 11
An integrated toolkit for human microglia functional genomics
Haq, I., Ngo, J. C., Roy, N., Pan, R., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03700-9 · Cited by 10
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau
Iyer, A. K., Vermunt, L., Mirfakhar, F. S., Minaya, M., Acquarone, M., Koppisetti, R. K., Renganathan, A., You, S., Danhash, E., Schache, K. J., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03073-2 · Cited by 14
Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer’s Disease
Young, J. E., & Goldstein, L. S. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_6 · Cited by 10
Replacement of Mouse Microglia With Human Induced Pluripotent Stem Cell (hiPSC)-Derived Microglia in Mouse Organotypic Slice Cultures
Ogaki, A., Ikegaya, Y., & Koyama, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.918442 · Cited by 10
Forward programming human pluripotent stem cells into microglia
Csatári, J., Wiendl, H., & Pawlowski, M. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.03.006 · Cited by 10
Emerging Models to Study Human Microglia In vitro
Jäntti, H., Kistemaker, L., Buonfiglioli, A., de Witte, L. D., Malm, T., & Hol, E. M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_30 · Cited by 8
Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils
Vanderperre, B., Muraleedharan, A., Dorion, M., Larroquette, F., del Cid‐Pellitero, E., Rajakulendran, N., Chen, C. X. ‐., Larivière, R., Michaud-Tardif, C., Goiran, T., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08786-2 · Cited by 18
Human-Induced Pluripotent Stem Cell–Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation
Allison, R. L., & Ebert, A. D. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad209 · Cited by 9
Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
Asiamah, E. A., Guo, R., Kong, D., Feng, B., He, J., Zhang, W., Liu, X., Du, X., Ma, Z., Liu, B., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0065 · Cited by 9
A Subpopulation of Microglia Generated in the Adult Mouse Brain Originates from Prominin-1-Expressing Progenitors
Prater, K. E., Aloi, M. S., Pathan, J. L., Winston, C. N., Chernoff, R. A., Davidson, S., Sadgrove, M. P., McDonough, A., Zierath, D. K., Su, W., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1893-20.2021 · Cited by 9
Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models
Bigarreau, J., Rouach, N., Perrier, A. L., Mouthon, F., & Charvériat, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031684 · Cited by 10
A genome-wide CRISPR/Cas9 screen identifies genes that regulate the cellular uptake of α-synuclein fibrils by modulating heparan sulfate proteoglycansPreprint
Vanderperre, B., Muraleedharan, A., Dorion, M., Larroquette, F., del Cid‐Pellitero, E., Rajakulendran, N., Chen, C. X., Larivière, R., Michaud-Tardif, C., Chidiac, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.29.560170 · Cited by 9
Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells
Bedford, L. M., Tutrow, K. D., Hooper, K., Messenger, E. J., Hernandez, M., Lamb, B. T., Meyer, J. S., Richardson, T. I., & Bissel, S. J. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70772 · Cited by 8
INPP5D/SHIP1 regulates inflammasome activation in human microglia
Chou, V., Fancher, S. B., Pearse, R. V., Lee, H., Lam, M., Seyfried, N. T., Bennett, D. A., De Jager, P. L., Menon, V., & Young-Pearse, T. L. (2023) · doi:10.1101/2023.02.25.530025 · Cited by 8
A versatile mouse model to advance human microglia transplantation research in neurodegenerative diseases
Serneels, L., Sierksma, A. S. R., Pasciuto, E., Geric, I., Nair, A. L., Martínez‐Muriana, A., Snellinx, A., & Strooper, B. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00823-2 · Cited by 8
High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
Cardona, C. L., Wei, L., Kim, J., Angeles, E., Singh, G., Chen, S., Patel, R., Ifediora, N., Canoll, P., Teich, A. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03562-9 · Cited by 8
Cell type-specific enhancer-promoter connectivity maps in the human brain and disease risk associationPreprint
Nott, A., Holtman, I., Coufal, N., Schlachetzki, J., Yu, M., Hu, R., Han, C. Z., Pena, M., Xiao, J., Wu, Y., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/778183 · Cited by 11
HDAC Inhibitors recapitulate Human Disease-Associated Microglia Signatures in vitroPreprint
Haage, V. C., Tuddenham, J. F., Bautista, A. R., White, C. C., Garcia, F. G., Patel, R., Comandante-Lou, N., Marshe, V. S., Soni, R. K., Sims, P. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.11.617544 · Cited by 8
Inhibition of Acyl‐CoenzymeA: Cholesterol Acyltransferase 1 promotes shedding of soluble triggering receptor on myeloid cells 2 (TREM2) and low‐density lipoprotein receptor 1 (LRP1)‐dependent phagocytosis of amyloid beta protein in microglia
Hovde, M. J., Maaser‐Hecker, A., Bae, J., & Tanzi, R. E. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70879 · Cited by 8
Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids
Govaerts, J., Breedam, E. V., Beuckeleer, S. D., Goethals, C., D’Incal, C. P., Stefano, J. D., Calster, S. V., Buyle-Huybrecht, T., Boeren, M., Reu, H. D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1458967 · Cited by 8
Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin
Young, A. P., & Denovan‐Wright, E. M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107443 · Cited by 7
Microglia-like cells from patient monocytes demonstrate increased phagocytic activity in probable Alzheimer's disease
Gonul, C. P., Kiser, C., Yaka, E. C., Öz, D., Hunerli, D., Yerlikaya, D., Olcum, M., Keskinoğlu, P., Yener, G., & Genç, Ş. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103990 · Cited by 8
CSF1R inhibitor-resistant model for CNS-wide microglia replacement strategies
Chadarevian, J. P., Nguyen, J., Le, L., Ayala, L. A., Chadarevian, A. L., Zhou, C., Escobar, A., Abby, T., Deynega, E., Mansour, K., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.051 · Cited by 7
Self-citation
Navigating the Complex Terrain of Dysregulated Microglial Function in Depressive Disorders: Insights, Challenges and Future Directions
Zhang, Y., & Tang, C. (2024) · Aging and Disease · doi:10.14336/ad.2024.0326 · Cited by 7
Perfluoroalkyl substance pollutants disrupt microglia function and trigger transcriptional and epigenomic changes
Cheng, Y., Li, J., Yu, H., Li, S., Tychhon, B., Cheng, C., & Weng, Y. (2025) · Toxicology · doi:10.1016/j.tox.2025.154198 · Cited by 8
Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research—What We Have Learnt and Not Learnt until Now
Simeon, M., Dangwal, S., Sachinidis, A., & Doss, M. X. (2021) · Cells · doi:10.3390/cells10113112 · Cited by 7
Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3
Haukedal, H., Lorenzen, S. S., Westi, E. W., Corsi, G. I., Gadekar, V. P., McQuade, A., Davtyan, H., Doncheva, N. T., Schmid, B., Chandrasekaran, A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.024 · Cited by 7
Self-citation
Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders
Michalski, C., & Wen, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1291115 · Cited by 7
Parkinson’s Disease Genetic Risk Evaluation in Microglia Highlights Autophagy and Lysosomal GenesPreprint
Booms, A., Pierce, S. E., & Coetzee, G. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.17.254276 · Cited by 7
PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s diseasePreprint
Monroe, K. M., Weerakkody, T. N., Sabelström, H., Tatarakis, D., Suh, J. H., Chin, M. Y., Andrews, S. V., Propson, N. E., Balasundar, S., Davis, S. S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3954863/v1 · Cited by 7
Self-citation
Human Microglia Models for NeuroHIV
Sarkar, P. A., Wang, X., Hu, W., Zhu, J. K., & Ho, W. (2025) · Viruses · doi:10.3390/v17050641 · Cited by 7
Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitro
Podlesny‐Drabiniok, A., Romero‐Molina, C., Patel, T., See, W. Y., Liu, Y., Marcora, E. M., & Goate, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115909 · Cited by 7
Transcriptional regulation of disease-relevant microglial activation programs
McQuade, A., Mishra, R., Hagan, V., Liang, W., Colias, P. J., Castillo, V. C., Gonzalez, B., Lubin, J. P., Haage, V. C., Marshe, V. S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.07.001 · Cited by 7
Self-citation
Protocol for generating a human iPSC-derived tri-culture model to study interactions between neurons, astrocytes, and microglia
Lish, A. M., Galle, P. C., Orme, G. A., Ashour, N., Heuer, S. E., Curle, A. J., Muratore, C., & Young‐Pearse, T. L. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.104152 · Cited by 6
Generation and characterization of iPSC‐derived microglia for in vitro modeling of stimuli‐specific neuroimmune responses
Haskell, A. K., Kulas, J. A., Carter, W., Javens‐Wolfe, J., Hinkel, R. D., Moussaif, M., Smiley, J. S., Lazaro, O., Robertson, S., Palkowitz, A. D., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71117 · Cited by 6
Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models
Blenkle, A., Geladaris, A., & Weber, M. S. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01647-w · Cited by 6
Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia
Kuhrt, L. D., Motta, E., Elmadany, N., Weidling, H., Fritsche‐Guenther, R., Efe, I. E., Cobb, O. M., Chatterjee, J., Boggs, L. G., Schnauss, M., et al. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049861 · Cited by 7
Human microglia-derived proinflammatory cytokines facilitate human retinal ganglion cell development and regeneration
Subramani, M., Lambrecht, B., & Ahmad, I. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.06.009 · Cited by 6
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference
Kloske, C. M., Mahinrad, S., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Butts, B., Carrillo, M. C., Chakrabarty, P., Chen, X., Craft, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14291 · Cited by 6
Comparing Alzheimer's genes in African, European, and Amerindian induced pluripotent stem cell–derived microglia
Moura, S., Nasciben, L. B., Ramírez, A. M., Coombs, L. E., Rivero, J., Booven, D. J. V., DeRosa, B. A., Hamilton‐Nelson, K. L., Whitehead, P. L., Adams, L. D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70031 · Cited by 6
Implications of gene × environment interactions in post-traumatic stress disorder risk and treatment
Seah, C., Sidamon‐Eristoff, A. E., Huckins, L. M., & Brennand, K. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185102 · Cited by 7
Cellular and molecular phenotypes of C9orf72 ALS/FTD patient derived iPSC-microglia mono-culturesPreprint
Lorenzini, I., Alsop, E. B., Levy, J., Gittings, L. M., Lall, D., Rabichow, B. E., Moore, S. R., Pevey, R. S., Bustos, L. M., Burciu, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.03.277459 · Cited by 6
Self-citation
BHLHE40/41 regulate macrophage/microglia responses associated with Alzheimer’s disease and other disorders of lipid-rich tissuesPreprint
Podleśny-Drabiniok, A., Novikova, G., Liu, Y.-Y., Dunst, J., Temizer, R., Giannarelli, C., Marro, S. G., Kreslavsky, T., Marcora, E., & Goate, A. (2023) · bioRxiv · doi:10.1101/2023.02.13.528372 · Cited by 5
Microglia contribute to bipolar depression through Serinc2-dependent phospholipid synthesis
Wang, Y.-H., Fu, C.-L., Chen, L., Zhang, C., Chen, J., Zhang, Q.-M., Liang, Y., Yang, R.-L., Li, Y., Zhang, Y., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2500116122 · Cited by 5
Advancing insights into virus-induced neurodevelopmental disorders through human brain organoid modelling
Crawford, G., Soper, O., Kang, E., & Berg, D. A. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.35 · Cited by 5
A Blueprint for Translational Precision Medicine in Autism Spectrum Disorder and Related Neurogenetic Syndromes
Thom, R. P., Warren, T. L., Khan, S., Muhle, R., Wang, P. P., Brennand, K., Zürcher, N. R., Veenstra-VanderWeele, J. M., & Hoffman, E. J. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2025.0023 · Cited by 5
Coordinated Transcriptional Waves Define the Inflammatory Response of Primary Microglial Culture
Zohar, K., Lezmi, E., Reichert, F., Eliyahu, T., Rotshenker, S., Weinstock, M., & Linial, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310928 · Cited by 5
Decoding Pain: Next‐Generation In Vitro Systems for Mechanistic Insights and Drug Discovery
Khosrowshahi, D., Lagae, L., & Bolander, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501025rr · Cited by 5
Lessons from ex vivo and in vitro models in microglia research
Cserép, C., Berki, P., Mars, M., Pósfai, B., Pasterkamp, R. J., Benkő, S., & Dénes, Á. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.10.004 · Cited by 5
IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology
Allison, R. L., Mangione, C. C., Suneja, M., Gawrys, J. E., Melvin, B. M., Belous, N., LaCroix, M., Harmelink, M. M., Burnett, B. G., & Ebert, A. D. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.12.016 · Cited by 4
Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling
Patel, R., Cheng, R., Cardona, C. L., Angeles, E., Singh, G., Miller, S., Ashok, A., Teich, A. F., Piriz, A. L., Maldonado, A., et al. (2026) · Glia · doi:10.1002/glia.70165 · Cited by 5
A Core Transcription Regulatory Circuitry Defining Microglia Cell Identity Inferred from the Reanalysis of Multiple Human Microglia Differentiation Protocols
Aubert, A., Stüder, F., Colombo, B. M., & Mendoza-Parra, M. A. (2021) · Brain Sciences · doi:10.3390/brainsci11101338 · Cited by 4
Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells
Knock, E., & Julian, L. M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.767457 · Cited by 5
IPSC-derived models in Africa: An HIV perspective
Naidoo, J., Hurrell, T., & Scholefield, J. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.013 · Cited by 4
Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Funes, S., & Bosco, D. A. (2022) · Journal of Visualized Experiments · doi:10.3791/64323 · Cited by 4
Assessing human iPSC-derived microglia identity and function by immunostaining, phagocytosis, calcium activity, and inflammation assay
Hübschmann, V., Korkut-Demirbaş, M., & Siegert, S. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101866 · Cited by 5
ER and SOCE Ca2+ signals are not required for directed cell migration in human iPSC-derived microglia
Granzotto, A., McQuade, A., Chadarevian, J. P., Davtyan, H., Sensi, S. L., Parker, I., Blurton-Jones, M. M., & Smith, I. F. (2024) · Cell Calcium · doi:10.1016/j.ceca.2024.102923 · Cited by 6
Self-citation
High-Yield Monocyte, Macrophage, and Dendritic Cell Differentiation From Induced Pluripotent Stem CellsPreprint
Armitage, L. H., Maharlooei, M. K., Meacham, A. M., Butfiloski, E. J., Viola, R., Egli, D. M., Sykes, M., Wallet, M. A., & Mathews, C. E. (2021) · SSRN Electronic Journal · doi:10.1101/2021.04.29.441947 · Cited by 5
Cell-type-specific regulation of APOE levels in human neurons by the Alzheimer’s disease risk gene SORL1Preprint
Lee, H., Aylward, A. J., Pearse, R. V., Hsieh, Y., Augur, Z. M., Benoit, C. R., Chou, V., Knupp, A., Pan, C., Goberdhan, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.25.530017 · Cited by 4
Air-liquid interface culture of midbrain organoids improves neuronal functionality and integration of microgliaPreprint
Kälvälä, S., Abushik, P. A., Dougalis, A., Malm, T., Pelkonen, A., & Lehtonen, Š. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.10.561672 · Cited by 4
Cholesterol Dysregulation in APOE4 Astrocytes Promotes α-Synuclein Pathology in miBrains, a Human Brain Tissue ModelPreprint
Mesentier-Louro, L. A., Goldman, C., Gaese, S., Buonfiglioli, A., Kyriakis, D., Harlock, A., Ndayisaba, A., Sartori, E. R., Uchitelev, A., Fullard, J. F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.09.637107 · Cited by 4
Long-term co-maturation of stem cell-derived microglia and neuronal networks: an optimized platform to assess human microglial contribution to neuronal functionPreprint
Mordelt, A., Schuurmans, I. M. E., Scheefhals, N., Hommersom, M. P., Slottje, K., Mast, K., Graziani, M., González, C. O., Wingens, L. J. A., Schubert, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684345 · Cited by 4
Conserved phenotype and function of human brain border-associated macrophages in iPSC-derived modelsPreprint
Barr, H. J., Depp, C., Hingerl, M., Nguyen, T. T. H., Reimertz, J. M., Connolly, E., Patel, J., Doman, J. L., Marsh, S. E., & Stevens, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693582 · Cited by 7
INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia
Terzioglu, G., Karp, E. S., Heuer, S. E., Chadarevian, J. P., Ahsan, F. M., Haage, V. C., Davtyan, H., Fogo, G. M., Curle, A. J., Ashour, N., et al. (2025) · doi:10.1101/2025.10.27.684632 · Cited by 3
Self-citation
Roles of central nervous system resident and recruited macrophages in the brain barrier system
Liu, Z., Cheng, T., Dong, H., Sun, D., Wang, Y., Li, J., Yu, Z., & Cao, L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00986 · Cited by 3
Sex differences on laser-induced choroidal neovascularization and short-chain fatty acid treatment in a mouse model
Yan, C., Figueiredo, C. A., Pompös, I.-M., Ugursu, B., Arribas-Lange, P., Skosyrski, S., Yang, S., Althoff, P., Kociok, N., Joussen, A. M., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03508-1 · Cited by 3
Extracellular microRNAs modulate human microglial function through TLR8
Weidling, H., Motta, E., Kuhrt, L. D., Krüger, C., Figueiredo, C. A., Wallach, T., Frahm, S., Diecke, S., Wolf, S. A., Kettenmann, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1645062 · Cited by 4
A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms
Chapleau, A., Perrier, S., Durcan, T. M., & Bernard, G. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00533-0 · Cited by 3

Authors: McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M.
Affiliations: University of California, Irvine (US)
Corresponding author: Blurton-Jones, Mathew
ORCID: McQuade, Amanda
Coburn, Morgan
Tu, Christina H.
Hasselmann, Jonathan
Davtyan, Hayk
Blurton-Jones, Mathew
Venue: Molecular Neurodegeneration
Publisher: Springer Science and Business Media LLC
Published: 2018-12
Volume: 13
Issue: 1
Pages: 67-67
ISSN: 1750-1326 (ISSN-L)
DOI: 10.1186/s13024-018-0297-x
PMC: PMC6303871
OpenAlex: W2905656859
Cited by: 449
References: 33
Citations by year: 2026: 64 · 2025: 98 · 2024: 73 · 2023: 53 · 2022: 54 · 2021: 43 · 2020: 40 · 2019: 23
FWCI: 11.92
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 21 d)
Locations: Molecular Neurodegeneration (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, other-oa)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: National Institutes of Health (AG048099, AG056303, AG016573)
California Institute for Regenerative Medicine (RT3-07893)
National Institute of Neurological Disorders and Stroke (NS082174)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: microglia differentiation, induced pluripotent stem cells, iPSC-derived microglia, hematopoietic progenitor cells, macrophage colony-stimulating factor, IL-34, TGF-β1, TGF-beta signaling, microglial transcriptome, neurodegeneration
MeSH terms: Animals, Brain, Cell Differentiation, Humans, Cytokines, Microglia, Pluripotent Stem Cells, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development and validation of a simplified method to generate human microglia from pluripotent stem cells

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks